[Comprehensive view of hepatitis and the other reactions secondary to antituberculosis chemotherapy].
D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology*; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D011718:Pyrazinamide / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin
Vue d'ensemble sur l'hépatite et les autres réactions secondaires à la chimiothérapie antituberculeuse.